Market Cap (In USD)
609.36 Thousand
Revenue (In USD)
1801.00
Net Income (In USD)
-38.31 Thousand
Avg. Volume
793.02 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.9E-4-0.0013
- PE
- -
- EPS
- -
- Beta Value
- 0.059
- ISIN
- US4657331033
- CUSIP
- 465733103
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Mr. Mark H. Cheung
- Employee Count
- -
- Website
- https://www.itonisholdings.com
- Ipo Date
- 2007-02-21
- Details
- Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
More Stocks
-
TEAMG
-
NAMSW
-
ANSINDUSANS Industries Limited
ANSINDUS
-
IBG
-
SYNEX
-
FAEFaes Farma, S.A.
FAE
-
ELEKElektros Inc.
ELEK
-
SYNEX-R